West Virginia Senate Bill SB 291

West Virginia 2026 Regular Session

• Introduced: 1/15/26
• Refer: 1/15/26

Caption

Insurance Commission rule relating to advertisement of accident and sickness insurance

Summary

SB 291 concerns a rule of the Insurance Commission governing advertisements for accident and sickness insurance. Based on the bill caption, the measure appears to address how insurers, agents, or related entities may advertise health-related insurance products, likely by adopting, revising, or authorizing a regulatory rule on advertising standards. Because the bill text was not available in the provided materials, the precise substantive changes cannot be identified from the record here. However, the bill would affect the state’s insurance regulatory framework by shaping the standards the Insurance Commission may apply to marketing and promotional materials for accident and sickness insurance, which can include disclosures, prohibited claims, and consumer-protection requirements.

Impact

The bill would likely affect Title 33 insurance regulation and the administrative authority of the West Virginia Insurance Commission over accident and sickness insurance advertising. Its practical impact would fall on insurers, producers, marketers, and consumers by potentially changing what must be disclosed in advertisements and what promotional practices are permitted or restricted. Without the underlying text, the exact statutory sections or rule provisions amended cannot be confirmed from the available record.

Sentiment

The available record shows the bill was referred to Senate Finance and does not include committee transcripts or recorded votes, so there is no direct evidence of debate, support, or opposition in the materials provided. The caption suggests a technical or regulatory measure rather than a broad policy overhaul, which often indicates a relatively routine legislative posture, but that cannot be verified from the record alone.

Contention

No specific points of contention are documented in the provided materials because there are no transcripts or votes attached. If there were concerns, they would likely center on the scope of the Insurance Commission’s rulemaking authority, the burden of advertising compliance on insurers and agents, and whether the rule would strengthen consumer protections or impose unnecessary restrictions on marketing.